1. Home
  2. SHFS vs CLDI Comparison

SHFS vs CLDI Comparison

Compare SHFS & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SHF Holdings Inc.

SHFS

SHF Holdings Inc.

N/A

Current Price

$0.15

Market Cap

2.7M

Sector

Finance

ML Signal

N/A

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

N/A

Current Price

$1.22

Market Cap

2.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHFS
CLDI
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SHFS
CLDI
Price
$0.15
$1.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
292.0K
42.6K
Earning Date
04-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
95.30
N/A
EPS
N/A
N/A
Revenue
$7,673,532.00
$45,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.09
52 Week High
$9.18
$1.93

Technical Indicators

Market Signals
Indicator
SHFS
CLDI
Relative Strength Index (RSI) 32.50 45.36
Support Level N/A $1.12
Resistance Level $0.21 $1.23
Average True Range (ATR) 0.01 0.08
MACD 0.00 -0.05
Stochastic Oscillator 12.72 4.00

Price Performance

Historical Comparison
SHFS
CLDI

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

Share on Social Networks: